The Centre for Medical Image Computing (CMIC) at University College London 27 (UCL) hosted a two-day workshop on placenta imaging on April 12 th and 13 th 2018. The 28 workshop consisted of 10 invited talks, 3 contributed talks, a poster session, a public 29 interaction session and a panel discussion about the future direction of placental imaging. 30
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Anna David opened the workshop on the first day by arguing why we should image the 49 placenta with MR ( Figure 1 ). The placenta's complexity as a dual circulatory system with an 50 integral barrier between the mother and fetus(es) make it the most difficult organ to access 51 in vivo. Great strides have been made in understanding the brain using magnetic resonance 52
imaging. Now this technique is being applied to increase our understanding of placental 53 structure and function. From a purely curious perspective the placenta is a fascinating organ 54 that functions as a respiratory, renal, hepatic, endocrine, and vascular system for the 55 developing fetus. The origins of the great obstetric syndromes of preterm birth, fetal growth 56 restriction and pre-eclampsia probably come down to abnormal placental development and 57 function. These conditions affect up to a third of all pregnancies and are a leading cause of 58 neonatal and maternal morbidity and death globally. MR imaging of the placenta may shed 59 light on the pathology of these complications as well as allow the response to novel 60 treatments to be evaluated. 61 62
Rohan Lewis presented his group's work on multiscale 3D imaging of the placenta. These 63 techniques allow identification of novel structures at the tissue, cellular and subcellular 64 level, which are inaccessible using traditional 2D imaging techniques. Furthermore, the 3D 65 approach demonstrates the spatial relationships between different features which allows 66 relation of structure to function. The ability to see features and cellular spatial 67
interrelationships that could not previously be visualised is leading to a new biological 68
understanding of the placenta and may lead to novel biomarkers and therapeutic 69 approaches. 70 71
Eric Jauniaux presented on the etiopathology of ultrasound signs in the diagnosis of 72 placenta accreta and abnormally invasive placental disorders. Current findings continue to 73 support the concept of a biologically defective decidua rather than a primarily abnormally 74 invasive trophoblast. Prior caesarean section surgery increases the risk of placenta praevia 75 and both adherent and invasive placenta accreta, suggesting that the endometrial/decidual 76 defect following the iatrogenic creation of a uterine myometrium scar has an adverse effect 77 on early implantation. Preferential attachment of the blastocyst to scar tissue facilitates 78 abnormally deep invasion of trophoblastic cells and interactions with the radial and arcuate 79 arteries. Subsequent high velocity maternal arterial inflow into the placenta creates large 80 lacunae, destroying the normal cotyledonary arrangement of the villi. 81 82
Adrien Desjardins spoke on photoacoustic and ultrasound imaging of the placenta. 83
Ultrasound imaging can be valuable to visualise the placenta for diagnostic and therapeutic 84
procedures. However, current-generation ultrasound probes based on electronic 85 components have several prominent limitations. For instance, they are unable to detect 86 tissue colour directly, and it can be challenging to miniaturise them to the sub-millimetre 87 scale for integration into minimally invasive devices. Optical methods for transmitting and 88 receiving ultrasound are emerging as alternatives to their electrical counterparts. They offer 89 several distinguishing advantages, including the potential to generate and detect broadband 90 ultrasound required for high resolution imaging. The talk focused on recent work on 91 photoacoustic imaging of the placenta, where ultrasound is generated in tissue using pulsed 92 light, and fibre-optic generation of reception of ultrasound from within medical devices for 93 M A N U S C R I P T technique to make a timely diagnosis of abnormal placentation that would allow for 106 appropriate planning of follow-up examinations and optimal scheduling of delivery needs to 107 be further investigated. Research programs will benefit from the use of well-defined 108 sequences, standardized imaging protocols, and robust computational methods. 109 110
A C C E P T E D
Anne-Elodie Millischer presented work using MRI with Gadolinium for the Diagnosis of 111
Abnormally Invasive Placenta. Ultrasound is the primary imaging modality for the diagnosis 112 of placenta accreta, but it is not sufficiently accurate. MRI morphologic criteria have 113 recently emerged as a useful tool in this setting, but their analysis is too subjective. 114
Gadolinium enhancement may improve the accuracy to diagnose abnormal invasive 115 placenta (AIP). Dynamic contrast gadolinium enhancement (DCE) MRI is emerging as a 116 reliable procedure to diagnose AIP for both junior and senior radiologists. Particularly, the 117 use of a specific pattern of enhancement, by allowing the extraction of tissular 118 enhancement parameters, enables a predictable distinction between placenta accreta and 119 normal placenta. 120 121
Daniel Taylor presented on public engagement as a route to improving the quality and 122 dissemination of research outcomes. There is increasing evidence to support this link, with a 123 corresponding increase in funders' expectations of detailed plans as part of applications. 124
However, there remain a number of perceived barriers across fields. 125 126
These issues were discussed further at the poster session, where feedback demonstrated a 127 clear appetite for public communication and involvement in this area. This is particularly 128 timely given the clear link to patient impact and evidence of benefits, such as "lead(ing) to 129 new research questions". There was also a clear perceived need to "reimagine the public 130 image of the placenta". Despite this, many felt unsure of where to start, including which 131 groups to target, methods of reaching them and how to access support. This correlates to 132 national feedback in the Factors Affecting Public Engagement UK survey [1]. 133 134
Given the growing field there is increasingly institutional and local support available, with 135 many universities, hospitals and biomedical research centres featuring teams to assist with 136 developing activity. This is matched with national support such as the NCCPE [2], INVOLVE 137 [3] and AHSNs [4] , which are good starting points. 138 139 ultrafast acquisition offers the possibility to analyze the flow with a high spatio-temporal 158 resolution and may allow to discriminate maternal and fetal circulation. 159 160
The second day of the workshop began with Andrew Melbourne presenting for Rosalind 161
Aughwane on MicroCT for imaging the human placenta. Little is known about the three-162 dimensional structure of the fetoplacental vascular tree, due to the small size of vessels and 163 complexity of branching structure. Micro-CT can capture this data in 3D volumes and opens 164 a new window into our understanding of the vascular structure both in normal pregnancy 165 and in major obstetric disorders including fetal growth restriction, pre-eclampsia and 166
complicated twin pregnancies. MicroCT shows that there is substantial heterogeneity in 167 vascular density within normal placentas, however some trends in the structure of the 168 vascular tree appear to be conserved. The technique applied to the placenta allows the 169 three-dimensional chorionic and deep branching vessel structure to be visualised and 170 quantified, and can transform our understanding and appreciation of this much 171 understudied but vital organ. 172 173
Mary Rutherford gave an outline of the NIH-funded Placenta Imaging Project: the aim of 174 this project is to develop an integrated MR approach to assess placental structure and 175 function, and utilise it to characterise inadequate placentation. She then went on to discuss 176 the links between placenta dysfunction and neonatal encephalopathy and perinatal brain 177 injury. 178 179
Ed Johnstone spoke about paying attention to the placenta to improve antenatal care: 180 during pregnancy monitoring attention is understandably focused on the fetus and the 181 mother. However, the placenta sits at the interface between the two and examining it is 182 essential if we are to gain a full picture of pregnancy health and well-being. Traditionally, 183
antenatal placental assessment has primarily been confined to determining placental 184 location, but more recently attention has focused on trying to gauge and measure placental 185 function and health in vivo, particularly in pregnancies at risk of poor outcomes. The 186 M A N U S C R I P T Outreach -more is needed to communicate the importance of the placenta, and better 211 understanding of its importance for future maternal and fetal health. Increasing public 212 education and understanding will help boost recruitment, and hopefully lead to more ex 213 utero placentas available for study ex utero after birth. Families will be more likely to donate 214 placentas if they understand the importance of the organ and the potential benefits of 215 placental examination and research to future pregnancies. 216 217
More Research into placental pathology is needed to understand the broad spectrum of 218 placental conditions and fetal compensation in response to poor placentation. Pre-219 pregnancy imaging and correlation with subsequent placentation is likely to be a key 220
research area, but is yet to be studied in detail. Very early imaging of pregnancy is also likely 221 to become more important, with aims of establishing the timing of future intervention, and 222 helping provide early prediction of outcome. 223 224
Imaging is vital for improving our understanding of placental physiology and efficiency. The discussion ended with some thoughts for the future and our hope to meet again next 261
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